InvestLog
ALUR Allurion Technologies Inc. logo

ALUR Allurion Technologies Inc.

Healthcare
$0.83+4.94%ClosedMarket Cap: $6.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-1.42

P/S

0.50

EV/EBITDA

-0.79

DCF Value

$-33.36

FCF Yield

-363.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

52.7%

Operating Margin

-211.2%

Net Margin

-264.7%

ROE

44.2%

ROA

-238.3%

ROIC

-503.2%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$2.9M$-6.1M$—
Q4 null$3.6M$-6.0M$—
FY null$15.2M$-28.8M$—
Q3 null$2.7M$-11.9M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$3.00

Target (Median)

$3.00

Target Range

$3.00 - $3.00

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Chardan CapitalBuy
2026-02-24
Chardan CapitalNeutral
2025-11-20

Trading Activity

Insider Trades

View All
Gibbons Brendan M.
SellTue Feb 17
Buch Ojas
SellTue Feb 17
Davin Michael Rdirector
SellFri Dec 05
Davin Michael Rdirector
SellFri Dec 05
Davin Michael Rdirector
SellFri Dec 05

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

—

Beta

-0.21

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Peers

ADAP logoADAPAEMD logoAEMDCOCH logoCOCHCODX logoCODXERNA logoERNALFWD logoLFWDNVNO logoNVNOPRPH logoPRPHVVOS logoVVOSXAIR logoXAIR